Skip to main content
Premium Trial:

Request an Annual Quote

DNAPrint Establishes Pharma Subsidiary to Affirm Commitment to Personalized Medicine

NEW YORK, Oct. 12 (GenomeWeb News) - DNAPrint Genomics has established a subsidiary, called DNAPrint Pharmaceuticals, to focus on personalized medicine, the company said today.


DNAPrint, which develops genomics-based products and services, said it will also be seeking funding for DNAPrint Pharmaceuticals. Hector Gomez, DNAPrint's chairman and chief medical officer, said the new subsidiary "affirms" its "commitment to the development" of new drugs and tests.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.